Combinations of RXFP1 modulators and SGLT2 inhibitors

The specification generally relates to combinations of RXFP1 modulators and SGLT2 inhibitors, in particular pharmaceutical compositions comprising such combinations, and therapeutic methods using such combinations.

Saved in:
Bibliographic Details
Main Authors PETTERSEN, DANIEL TOR, GABRIELSEN, ANDERS, CONNOLLY, KATHLEEN MARIE, UFNAL, MARCIN
Format Patent
LanguageChinese
English
Published 16.04.2024
Subjects
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The specification generally relates to combinations of RXFP1 modulators and SGLT2 inhibitors, in particular pharmaceutical compositions comprising such combinations, and therapeutic methods using such combinations.
Bibliography:Application Number: TW202312121132